The spectrum of inflammatory blood vessel diseases includes both atherosclerosis and the
primary systemic vasculitides. Although the inciting triggers differ, significant overlap exists …

Background and objectives The optimization of immunosuppressive therapies has led to a
marked improvement in the survival of ANCA-associated vasculitides (AAV). The main issue …

The present review summarizes the burden, risk factors, biomarkers of and therapeutic
consideration for cardiovascular disease in systemic vasculitis. Ischemic heart disease (IHD) …

Systemic vasculitis are disabling complex disorders potentially involving any organ and
system. Tremendous efforts have been made recently in this field with novel insights into …

Abstract Purpose of Review Eosinophilic granulomatosis with polyangiitis (EGPA)
represents a rare clinical entity, which is getting increasing attention and relevance in view …

Despite improvement in the prognosis of ANCA-associated vasculitides (AAVs), increased
mortality, mainly from a cardiovascular origin, persists. We aimed to determine the role of …

Aim Taking into account the ambiguous results of previously published studies on
endothelial dysfunction in systemic sclerosis, we sought to determine the validity laboratory …

Abstract Objectives Systemic vasculitides (SVs) are a highly inflammatory group of diseases
characterized by significant cardiovascular (CV) mortality. Microvascular damage closely …

Objective Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with a
variable clinical manifestation, potentially leading to death. Importantly, patients with SLE …

Objectives Systemic vasculitis is a heterogenous group of autoimmune diseases
characterized by enhanced cardiovascular mortality. Endothelial dysfunction is associated …